Literature DB >> 34949658

Bioinformatic Prediction of Novel Signaling Pathways of Apoptosis-inducing Factor, Mitochondrion-associated 3 (AIFM3) and Their Roles in Metastasis of Cholangiocarcinoma Cells.

Daraporn Chua-On1, Tanakorn Proungvitaya1, Anchalee Techasen1,2, Temduang Limpaiboon1,2, Sittiruk Roytrakul3, Doungdean Tummanatsakun1, Norie Araki4, Siriporn Proungvitaya5,2.   

Abstract

BACKGROUND/AIM: We previously demonstrated that a mitochondrial protein, apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) is over-expressed in cholangiocarcinoma (CCA) and its serum levels can be a prognostic biomarker for CCA. To elucidate the functional roles of AIFM3 in CCA progression, we aimed to determine the signaling pathways of AIFM3 in CCA.
MATERIALS AND METHODS: AIFM3 gene in CCA cells was silenced and AIFM3-related proteins were identified using mass spectrometry and bioinformatics tools. The relationships between AIFM3 and 441 related proteins were explored. To validate the functions of AIFM3, transwell migration/invasion assays were used.
RESULTS: Bioinformatic analyses predicted that AIFM3 interacts with formin-like protein 3 (FMNL3) and is involved in tumor cell motilities. Online database analysis revealed higher AIFM3 mRNA expression levels in CCA, particularly with lymph node metastasis. After AIFM3 gene silencing, CCA cell migration/invasion was significantly decreased (p<0.001). Furthermore, AIFM3 expression levels were significantly associated with lymph node metastasis (p=0.0009) and shorter survival time (p=0.020).
CONCLUSION: The AIFM3 signaling pathway is mediated via FMNL3 and involved in metastasis, suggesting that AIFM3 might be a molecular target to prevent CCA metastasis.
Copyright © 2022, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  AIFM3; Cholangiocarcinoma; bioinformatics; mass spectrometry; metastasis; signaling pathway

Mesh:

Substances:

Year:  2022        PMID: 34949658      PMCID: PMC8717952          DOI: 10.21873/cgp.20302

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  37 in total

1.  Establishment of a highly differentiated immortalized human cholangiocyte cell line with SV40T and hTERT.

Authors:  Masanobu Maruyama; Naoya Kobayashi; Karen A Westerman; Masakiyo Sakaguchi; Jean E Allain; Toshinori Totsugawa; Teru Okitsu; Takuya Fukazawa; Anne Weber; Donna B Stolz; Philippe Leboulch; Noriaki Tanaka
Journal:  Transplantation       Date:  2004-02-15       Impact factor: 4.939

2.  Serum pyruvate dehydrogenase kinase as a prognostic marker for cholangiocarcinoma.

Authors:  Surangkana Sanmai; Tanakorn Proungvitaya; Temduang Limpaiboon; Daraporn Chua-On; Wunchana Seubwai; Sittiruk Roytrakul; Sopit Wongkham; Chaisiri Wongkham; Ongart Somintara; Sakkarn Sangkhamanon; Siriporn Proungvitaya
Journal:  Oncol Lett       Date:  2019-03-22       Impact factor: 2.967

3.  Molecular cloning and characterization of a human AIF-like gene with ability to induce apoptosis.

Authors:  Qiang Xie; Tianxin Lin; Yan Zhang; Jianping Zheng; Joseph A Bonanno
Journal:  J Biol Chem       Date:  2005-03-11       Impact factor: 5.157

4.  Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100).

Authors:  Banchob Sripa; Saman Leungwattanawanit; Takayuki Nitta; Chaisiri Wongkham; Vajarabhongsa Bhudhisawasdi; Anucha Puapairoj; Chongrak Sripa; Masanao Miwa
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

5.  UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.

Authors:  Darshan S Chandrashekar; Bhuwan Bashel; Sai Akshaya Hodigere Balasubramanya; Chad J Creighton; Israel Ponce-Rodriguez; Balabhadrapatruni V S K Chakravarthi; Sooryanarayana Varambally
Journal:  Neoplasia       Date:  2017-07-18       Impact factor: 5.715

6.  ANKRD22, a novel tumor microenvironment-induced mitochondrial protein promotes metabolic reprogramming of colorectal cancer cells.

Authors:  Tianhui Pan; Jingwen Liu; Song Xu; Qiao Yu; Hongping Wang; Hongxiang Sun; Jia Wu; Yue Zhu; Jianwei Zhou; Yongliang Zhu
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

7.  Survival after surgery among patients with cholangiocarcinoma in Northeast Thailand according to anatomical and morphological classification.

Authors:  Chaiwat Tawarungruang; Narong Khuntikeo; Nittaya Chamadol; Vallop Laopaiboon; Jaruwan Thuanman; Kavin Thinkhamrop; Matthew Kelly; Bandit Thinkhamrop
Journal:  BMC Cancer       Date:  2021-05-03       Impact factor: 4.430

8.  Significant evidence of linkage for a gene predisposing to colorectal cancer and multiple primary cancers on 22q11.

Authors:  Craig Teerlink; Quentin Nelson; Randall Burt; Lisa Cannon-Albright
Journal:  Clin Transl Gastroenterol       Date:  2014-02-27       Impact factor: 4.488

9.  jvenn: an interactive Venn diagram viewer.

Authors:  Philippe Bardou; Jérôme Mariette; Frédéric Escudié; Christophe Djemiel; Christophe Klopp
Journal:  BMC Bioinformatics       Date:  2014-08-29       Impact factor: 3.169

10.  Subpopulation targeting of pyruvate dehydrogenase and GLUT1 decouples metabolic heterogeneity during collective cancer cell invasion.

Authors:  R Commander; C Wei; A Sharma; J K Mouw; L J Burton; E Summerbell; D Mahboubi; R J Peterson; J Konen; W Zhou; Y Du; H Fu; M Shanmugam; A I Marcus
Journal:  Nat Commun       Date:  2020-03-24       Impact factor: 14.919

View more
  2 in total

1.  Prediction of Angiopoietin-like Protein 4-related Signaling Pathways in Cholangiocarcinoma Cells.

Authors:  Tin May Aung; Atit Silsirivanit; Apinya Jusakul; Waraporn Chan-On; Tanakorn Proungvitaya; Sittiruk Roytrakul; Siriporn Proungvitaya
Journal:  Cancer Genomics Proteomics       Date:  2022 Jul-Aug       Impact factor: 3.395

2.  Prediction of CIAPIN1 (Cytokine-Induced Apoptosis Inhibitor 1) Signaling Pathway and Its Role in Cholangiocarcinoma Metastasis.

Authors:  Son Dinh An Truong; Molin Wongwattanakul; Tanakorn Proungvitaya; Temduang Limpaiboon; Sittiruk Roytrakul; Daraporn Chua-On; Doungdean Tummanatsakun; Siriporn Proungvitaya
Journal:  J Clin Med       Date:  2022-07-01       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.